US regulators relax restrictions on rosiglitazone.
作者信息
McCarthy Michael
机构信息
Seattle.
出版信息
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
PMID:24286989
Abstract
摘要
相似文献
1
US regulators relax restrictions on rosiglitazone.
BMJ. 2013 Nov 28;347:f7144. doi: 10.1136/bmj.f7144.
2
Rosiglitazone, medical reversal, and back to basics for diabetes.
Am Fam Physician. 2014 Sep 15;90(6):368, 370.
3
FDA panel advises easing restrictions on rosiglitazone.
BMJ. 2013 Jun 10;346:f3769. doi: 10.1136/bmj.f3769.
4
Diabetes drug safety update: Avandia and your heart.
Johns Hopkins Med Lett Health After 50. 2010 Jun;22(4):1-2, 7.
5
The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
N Engl J Med. 2007 Aug 30;357(9):844-6. doi: 10.1056/NEJMp078167. Epub 2007 Aug 8.
6
Rosiglitazone and implications for pharmacovigilance.
BMJ. 2007 Jun 16;334(7606):1233-4. doi: 10.1136/bmj.39245.502546.BE.
7
Rosiglitazone.
Prim Care Diabetes. 2009 May;3(2):123-4. doi: 10.1016/j.pcd.2009.05.002. Epub 2009 May 30.
8
Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety.
JAMA. 2013 Jul 17;310(3):246-7. doi: 10.1001/jama.2013.8141.
9
[Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
MMW Fortschr Med. 2003 May 8;145(19):41.
10
The long Avandia endgame.
Lancet. 2011 Jul 9;378(9786):113. doi: 10.1016/s0140-6736(11)61071-4.
引用本文的文献
1
Bayesian estimation and testing in random-effects meta-analysis of rare binary events allowing for flexible group variability.
Stat Med. 2023 May 20;42(11):1699-1721. doi: 10.1002/sim.9695. Epub 2023 Mar 4.
2
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.
BMJ. 2020 Feb 5;368:l7078. doi: 10.1136/bmj.l7078.
3
Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
J Cell Mol Med. 2019 Jul;23(7):4779-4794. doi: 10.1111/jcmm.14366. Epub 2019 May 13.
4
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert.
Med Care. 2016 Apr;54(4):406-13. doi: 10.1097/MLR.0000000000000502.
5
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes.
J Clin Med. 2014 Aug 14;3(3):923-43. doi: 10.3390/jcm3030923.
6
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.
World J Diabetes. 2015 Feb 15;6(1):109-24. doi: 10.4239/wjd.v6.i1.109.
Zotero 插件